{"id":140397,"date":"2022-06-15T11:20:51","date_gmt":"2022-06-15T11:20:51","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/perguntas-frequentes\/"},"modified":"2025-11-13T17:00:37","modified_gmt":"2025-11-13T17:00:37","slug":"perguntas-frequentes","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/pt-br\/perguntas-frequentes\/","title":{"rendered":"Perguntas frequentes"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;111541&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;140228&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Perguntas frequentes<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_size=&#8221;&#8221; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;114728&#8243; text_color_type=&#8221;uncode-palette&#8221;]SUAS PERGUNTAS RESPONDIDAS.[\/vc_custom_heading][vc_empty_space empty_h=&#8221;1&#8243;][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112249&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center bottom&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;114217&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;166716&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Perguntas frequentes<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_size=&#8221;&#8221; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;105352&#8243; text_color_type=&#8221;uncode-palette&#8221;]SUAS PERGUNTAS RESPONDIDAS.[\/vc_custom_heading][vc_empty_space empty_h=&#8221;1&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112248&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;308018&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;2&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-514338&#8243; text_size=&#8221;h4&#8243; text_weight=&#8221;300&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;134194&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\">Perguntas frequentes<\/span>[\/vc_custom_heading][vc_custom_heading text_color=&#8221;color-196438&#8243; heading_semantic=&#8221;h1&#8243; text_font=&#8221;font-195745&#8243; text_weight=&#8221;600&#8243; sub_lead=&#8221;yes&#8221; sub_reduced=&#8221;yes&#8221; uncode_shortcode_id=&#8221;420235&#8243; text_color_type=&#8221;uncode-palette&#8221;]SUAS PERGUNTAS RESPONDIDAS.[\/vc_custom_heading][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;step_1_2&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; changer_back_color=&#8221;yes&#8221; uncode_shortcode_id=&#8221;120331&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;questions&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;5&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;166430&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;384218&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas gerais[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;999729&#8243; subheading=&#8221;Sua sa\u00fade ser\u00e1 monitorada continuamente durante todo o estudo StrateGIST 3. Mesmo se voc\u00ea n\u00e3o se beneficiar diretamente da participa\u00e7\u00e3o no estudo, quaisquer informa\u00e7\u00f5es obtidas poder\u00e3o ajudar os pesquisadores a descobrirem mais sobre o medicamento experimental, o IDRX-42, e o tratamento de outros adultos com GIST no futuro.&#8221;]Quais s\u00e3o as vantagens de participar do StrateGIST 3?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;146860&#8243; subheading=&#8221;Como ocorre com todos os medicamentos, existe um risco de efeitos colaterais devidos aos medicamentos em estudo. Mas sua seguran\u00e7a \u00e9 a nossa principal prioridade. Sua sa\u00fade ser\u00e1 monitorada de perto durante todo o estudo. Um grupo especial de profissionais, chamado Comit\u00ea de Monitoramento de Dados, tamb\u00e9m analisar\u00e1 os dados por todo o estudo para se certificar de que os participantes permane\u00e7am em seguran\u00e7a.&#8221;]H\u00e1 riscos em participar do estudo?[\/vc_custom_heading][vc_custom_heading 1=&#8221;biopharmaceutical&#8221; 2=&#8221;company&#8221; 3=&#8221;IDRx,&#8221; 4=&#8221;Inc.&#8221; 5=&#8221;is&#8221; 6=&#8221;sponsoring&#8221; 7=&#8221;the&#8221; 8=&#8221;clinical&#8221; 9=&#8221;trial.&#8221; 10=&#8221;They&#8221; 11=&#8221;will&#8221; 12=&#8221;pay&#8221; 13=&#8221;the&#8221; 14=&#8221;study&#8221; 15=&#8221;doctor&#8221; 16=&#8221;and&#8221; 17=&#8221;site&#8221; 18=&#8221;staff&#8221; 19=&#8221;to&#8221; 20=&#8221;run&#8221; 21=&#8221;this&#8221; 22=&#8221;trial.&#8221; 23=&#8221;To&#8221; 24=&#8221;learn&#8221; 25=&#8221;more&#8221; 26=&#8221;about&#8221; 27=&#8221;IDRx,&#8221; 28=&#8221;visit&#8221; 29=&#8221;&#8221; 30=&#8221;href=&#8220;&#8220;https:\/\/www.idrx.com&#8220;&#8220;&gt;www.idrx.com&#8221; 31=&#8221;.&#8220;&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;148716&#8243;]Quem est\u00e1 patrocinando o estudo cl\u00ednico StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;203685&#8243; css=&#8221;.vc_custom_1731516055759{margin-top: 10px !important;}&#8221;]<span style=\"font-weight: 400\">A empresa biofarmac\u00eautica global GSK est\u00e1 patrocinando o estudo cl\u00ednico StrateGIST 3. Ela pagar\u00e1 os m\u00e9dicos do estudo e a equipe do estudo para conduzi-lo. Para saber mais sobre a GSK, visite <\/span><a href=\"https:\/\/www.idrx.com\/\" target=\"_blank\" rel=\"noopener\">www.gsk.com<\/a>.[\/vc_column_text][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;150124&#8243; subheading=&#8221;O tratamento do estudo, as consultas do estudo e os testes\/exames relacionados ao estudo ser\u00e3o pagos pela patrocinadora do estudo cl\u00ednico, a GSK, e n\u00e3o custar\u00e3o nada a voc\u00ea. Voc\u00ea receber\u00e1 reembolso de gastos razo\u00e1veis com transporte relacionados \u00e0s consultas do estudo.&#8221;]Terei algum custo para participar do estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;430406&#8243; subheading=&#8221;A participa\u00e7\u00e3o em um estudo cl\u00ednico \u00e9 volunt\u00e1ria. Se decidir participar e depois mudar de ideia, voc\u00ea poder\u00e1 sair do estudo a qualquer momento. Sair do estudo n\u00e3o afetar\u00e1 seu tratamento m\u00e9dico regular.&#8221;]E se eu decidir participar do estudo e depois mudar de ideia?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;115706&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas sobre o medicamento experimental[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;138330&#8243; subheading=&#8221;O GIST \u00e9 frequentemente causado por altera\u00e7\u00f5es, ou muta\u00e7\u00f5es, em um gene de uma prote\u00edna celular normal chamado KIT. Essas muta\u00e7\u00f5es levam a superativa\u00e7\u00e3o do KIT (como um interruptor empacado na posi\u00e7\u00e3o \u201cligado\u201d), o que faz com que c\u00e9lulas cancerosas se multipliquem.<\/p>\n<p>O IDRX-42 \u00e9 um inibidor da tirosina quinase (TKI). TKIs param ou retardam a atividade do KIT e o crescimento de c\u00e9lulas cancerosas resultante. Outros TKIs s\u00e3o usados no GIST, mas podem n\u00e3o funcionar contra todas as muta\u00e7\u00f5es do <i>KIT<\/i>. O IDRX-42 foi elaborado para cobrir uma gama mais ampla de muta\u00e7\u00f5es do <i>KIT<\/i>.&#8221;]O que \u00e9 o IDRX-42?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;172011&#8243; subheading=&#8221;Como acontece com todos os medicamentos, existe a possibilidade de efeitos colaterais, que s\u00e3o efeitos indesejados e n\u00e3o intencionais de um medicamento. Converse com o m\u00e9dico do estudo para obter mais informa\u00e7\u00f5es sobre poss\u00edveis efeitos colaterais. Sua sa\u00fade ser\u00e1 monitorada atentamente durante todo o estudo. Informe o m\u00e9dico do estudo se notar quaisquer efeitos colaterais ou altera\u00e7\u00f5es na sua sa\u00fade.&#8221;]Existem efeitos colaterais causados pelos medicamentos em estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;114741&#8243; subheading=&#8221;Sim, o m\u00e9dico do estudo informar\u00e1 a voc\u00ea qual tratamento do estudo voc\u00ea est\u00e1 recebendo.<\/p>\n<p>Se eu receber sunitinibe, terei a chance de receber o IDRX-42? Se estiver tomando sunitinibe e seu c\u00e2ncer piorar, voc\u00ea talvez possa passar para o IDRX-42.&#8221;]Saberei se estou recebendo IDRX-42 ou sunitinibe?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;123134&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas sobre o StrateGIST 3[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;699296&#8243; subheading=&#8221;Voc\u00ea permanecer\u00e1 no estudo por at\u00e9 5 anos. Como ocorre com todos os estudos cl\u00ednicos, voc\u00ea poder\u00e1 parar de participar a qualquer momento, por qualquer raz\u00e3o ou sem raz\u00e3o. IDRX, Inc. does not have any plans to provide IDRX-42 or any other study drugs or procedures to you after the end of the trial or if you have discontinued or have been withdrawn from the trial.&#8221;]Por quanto tempo ficarei no estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;127156&#8243; subheading=&#8221;Se voc\u00ea se atender aos crit\u00e9rios de inclus\u00e3o para o estudo, ser\u00e1 colocado(a) de maneira aleat\u00f3ria em um grupo para receber IDRX-42 ou sunitinibe, um tratamento aprovado em alguns pa\u00edses para o tipo de GIST sendo estudado.&#8221;]Qual tratamento em estudo vou receber?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;514493&#8243; subheading=&#8221;O IDRX-42 vir\u00e1 sob a forma de comprimidos que voc\u00ea tomar\u00e1 pela boca com \u00e1gua (com ou sem alimento). Voc\u00ea tomar\u00e1 o IDRX-42 uma vez ao dia ou como indicado pelo m\u00e9dico do estudo. Voc\u00ea continuar\u00e1 a tomar o IDRX-42 enquanto seu c\u00e2ncer n\u00e3o piorar e voc\u00ea estiver tolerando o tratamento.&#8221;]Como deverei tomar o IDRX-42?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;355188&#8243; subheading=&#8221;O sunitinibe vir\u00e1 sob a forma de c\u00e1psulas que voc\u00ea tomar\u00e1 pela boca com \u00e1gua (com ou sem alimento). O sunitinibe ser\u00e1 tomado uma vez ao dia por 28 dias consecutivos, seguidos de uma pausa de 14 dias, a menos que voc\u00ea receba instru\u00e7\u00f5es diferentes. Voc\u00ea continuar\u00e1 a tomar o sunitinibe enquanto seu c\u00e2ncer n\u00e3o piorar e voc\u00ea estiver tolerando o tratamento. Se estiver tomando sunitinibe e seu c\u00e2ncer piorar, voc\u00ea talvez possa passar para o IDRX-42.&#8221;]Como deverei tomar o sunitinibe?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;700478&#8243;]Quais centros de pesquisa est\u00e3o participando do StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;480045&#8243; css=&#8221;.vc_custom_1732655988927{margin-top: 10px !important;}&#8221;]Clique <a href=\"\/#location\">aqui<\/a> para ver uma lista completa dos centros participantes e para encontrar um local pr\u00f3ximo de voc\u00ea.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;112276&#8243; back_attachment=&#8221;fixed&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;0&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; top_divider=&#8221;step_1_2&#8243; medium_visibility=&#8221;yes&#8221; changer_back_color=&#8221;yes&#8221; uncode_shortcode_id=&#8221;111832&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;questions&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;5&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;166430&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;384218&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas gerais[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;204481&#8243; subheading=&#8221;Nenhum benef\u00edcio \u00e9 garantido, mas sua sa\u00fade ser\u00e1 monitorada continuamente durante todo o estudo StrateGIST 3. Mesmo se voc\u00ea n\u00e3o se beneficiar diretamente da participa\u00e7\u00e3o no estudo, quaisquer informa\u00e7\u00f5es obtidas poder\u00e3o ajudar os pesquisadores a descobrirem mais sobre o medicamento experimental, o IDRX-42 (GSK6042981), e o tratamento de outros adultos com GIST no futuro.&#8221;]Quais s\u00e3o as vantagens de participar do StrateGIST 3?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;104022&#8243; subheading=&#8221;Como ocorre com todos os medicamentos, existe um risco de efeitos colaterais devidos aos medicamentos em estudo. Mas sua seguran\u00e7a \u00e9 a nossa principal prioridade. Sua sa\u00fade ser\u00e1 monitorada de perto durante todo o estudo.&#8221;]H\u00e1 riscos em participar do estudo?[\/vc_custom_heading][vc_custom_heading 1=&#8221;biopharmaceutical&#8221; 2=&#8221;company&#8221; 3=&#8221;IDRx,&#8221; 4=&#8221;Inc.&#8221; 5=&#8221;is&#8221; 6=&#8221;sponsoring&#8221; 7=&#8221;the&#8221; 8=&#8221;clinical&#8221; 9=&#8221;trial.&#8221; 10=&#8221;They&#8221; 11=&#8221;will&#8221; 12=&#8221;pay&#8221; 13=&#8221;the&#8221; 14=&#8221;study&#8221; 15=&#8221;doctor&#8221; 16=&#8221;and&#8221; 17=&#8221;site&#8221; 18=&#8221;staff&#8221; 19=&#8221;to&#8221; 20=&#8221;run&#8221; 21=&#8221;this&#8221; 22=&#8221;trial.&#8221; 23=&#8221;To&#8221; 24=&#8221;learn&#8221; 25=&#8221;more&#8221; 26=&#8221;about&#8221; 27=&#8221;IDRx,&#8221; 28=&#8221;visit&#8221; 29=&#8221;&#8221; 30=&#8221;href=&#8220;&#8220;https:\/\/www.idrx.com&#8220;&#8220;&gt;www.idrx.com&#8221; 31=&#8221;.&#8220;&#8221; heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;657637&#8243;]Quem est\u00e1 patrocinando o estudo StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;779402&#8243; css=&#8221;.vc_custom_1755617742215{margin-top: 10px !important;}&#8221;]<span style=\"font-weight: 400;\">A empresa biofarmac\u00eautica global GSK est\u00e1 patrocinando o estudo cl\u00ednico StrateGIST 3. Ela pagar\u00e1 os m\u00e9dicos do estudo e a equipe do estudo para conduzi-lo. Para saber mais sobre a GSK, visite <\/span><a href=\"https:\/\/us.gsk.com\/en-us\/\" target=\"_blank\" rel=\"noopener\">www.gsk.com<\/a>.[\/vc_column_text][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;500375&#8243; subheading=&#8221;O tratamento do estudo, as consultas do estudo e os testes\/exames relacionados ao estudo ser\u00e3o pagos pela patrocinadora do estudo cl\u00ednico, a GSK, e n\u00e3o custar\u00e3o nada a voc\u00ea.&#8221;]Terei algum custo para participar do estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;430406&#8243; subheading=&#8221;A participa\u00e7\u00e3o em um estudo cl\u00ednico \u00e9 volunt\u00e1ria. Se decidir participar e depois mudar de ideia, voc\u00ea poder\u00e1 sair do estudo a qualquer momento. Sair do estudo n\u00e3o afetar\u00e1 seu tratamento m\u00e9dico regular.&#8221;]E se eu decidir participar do estudo e depois mudar de ideia?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;115706&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas sobre o medicamento experimental[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;159505&#8243; subheading=&#8221;O GIST \u00e9 frequentemente causado por altera\u00e7\u00f5es, ou muta\u00e7\u00f5es, em um gene de uma prote\u00edna celular normal chamado KIT. Essas muta\u00e7\u00f5es levam a superativa\u00e7\u00e3o do KIT (como um interruptor empacado na posi\u00e7\u00e3o \u201cligado\u201d), o que faz com que c\u00e9lulas cancerosas se multipliquem.<\/p>\n<p>O IDRX-42 (GSK6042981) \u00e9 um inibidor da tirosina quinase (TKI). TKIs param ou retardam a atividade do KIT e o crescimento de c\u00e9lulas cancerosas resultante. Outros TKIs s\u00e3o usados no GIST, mas podem n\u00e3o funcionar contra todas as muta\u00e7\u00f5es do KIT. O IDRX-42 (GSK6042981) foi elaborado para cobrir uma gama mais ampla de muta\u00e7\u00f5es do KIT.&#8221;]O que \u00e9 o IDRX-42 (GSK6042981)?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;172011&#8243; subheading=&#8221;Como acontece com todos os medicamentos, existe a possibilidade de efeitos colaterais, que s\u00e3o efeitos indesejados e n\u00e3o intencionais de um medicamento. Converse com o m\u00e9dico do estudo para obter mais informa\u00e7\u00f5es sobre poss\u00edveis efeitos colaterais. Sua sa\u00fade ser\u00e1 monitorada atentamente durante todo o estudo. Informe o m\u00e9dico do estudo se notar quaisquer efeitos colaterais ou altera\u00e7\u00f5es na sua sa\u00fade.&#8221;]Existem efeitos colaterais causados pelos medicamentos em estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;135699&#8243; subheading=&#8221;Sim, o m\u00e9dico do estudo informar\u00e1 a voc\u00ea qual tratamento do estudo voc\u00ea est\u00e1 recebendo.&#8221;]Saberei se estou recebendo IDRX-42 (GSK6042981)<br \/>\nou sunitinibe?[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_custom_heading text_color=&#8221;color-681992&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;123134&#8243; text_color_type=&#8221;uncode-palette&#8221;]Perguntas sobre o StrateGIST 3[\/vc_custom_heading][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column_inner][vc_column_inner width=&#8221;2\/3&#8243;][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;756369&#8243; subheading=&#8221;Voc\u00ea permanecer\u00e1 no estudo por at\u00e9 5 anos. Como ocorre com todos os estudos cl\u00ednicos, voc\u00ea poder\u00e1 parar de participar a qualquer momento, por qualquer raz\u00e3o ou sem raz\u00e3o.&#8221;]Por quanto tempo ficarei no estudo?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;124602&#8243; subheading=&#8221;Se voc\u00ea se atender aos crit\u00e9rios de inclus\u00e3o para o estudo, ser\u00e1 colocado(a) de maneira aleat\u00f3ria em um grupo para receber IDRX-42 (GSK6042981) ou sunitinibe, um tratamento aprovado em alguns pa\u00edses para o tipo de GIST sendo estudado. Ao final do estudo, se voc\u00ea se qualificar, a GSK poder\u00e1 oferecer acesso ao IDRX-42 (GSK6042981) atrav\u00e9s de um programa de acesso separado dependendo dos regulamentos locais.&#8221;]Qual tratamento em estudo vou receber?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;191460&#8243; subheading=&#8221;O IDRX-42 (GSK6042981) vir\u00e1 sob a forma de comprimidos que voc\u00ea tomar\u00e1 oralmente com \u00e1gua (com ou sem alimento). Voc\u00ea tomar\u00e1 o IDRX-42 (GSK6042981) uma vez ao dia ou como indicado pelo m\u00e9dico do estudo. Voc\u00ea continuar\u00e1 a tomar o IDRX-42 (GSK6042981) enquanto seu c\u00e2ncer n\u00e3o piorar e voc\u00ea estiver tolerando o tratamento.&#8221;]Como deverei tomar o IDRX-42 (GSK6042981)?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152983&#8243; subheading=&#8221;O sunitinibe vir\u00e1 sob a forma de c\u00e1psulas que voc\u00ea tomar\u00e1 oralmente com \u00e1gua (com ou sem alimento). O sunitinibe ser\u00e1 tomado uma vez ao dia por 28 dias consecutivos, seguidos de uma pausa de 14 dias, a menos que voc\u00ea receba instru\u00e7\u00f5es diferentes. Voc\u00ea continuar\u00e1 a tomar o sunitinibe enquanto seu c\u00e2ncer n\u00e3o piorar e voc\u00ea estiver tolerando o tratamento.&#8221;]Como deverei tomar o sunitinibe?[\/vc_custom_heading][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;&#8221; sub_reduced=&#8221;yes&#8221; text_align=&#8221;text-left&#8221; text_serif=&#8221;yes&#8221; uncode_shortcode_id=&#8221;700478&#8243;]Quais centros de pesquisa est\u00e3o participando do StrateGIST 3?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;480045&#8243; css=&#8221;.vc_custom_1732655988927{margin-top: 10px !important;}&#8221;]Clique <a href=\"\/#location\">aqui<\/a> para ver uma lista completa dos centros participantes e para encontrar um local pr\u00f3ximo de voc\u00ea.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-xsdn&#8221; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-140397","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages\/140397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/comments?post=140397"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/pages\/140397\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/pt-br\/wp-json\/wp\/v2\/media?parent=140397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}